Institution
University of Milan
Education•Milan, Italy•
About: University of Milan is a education organization based out in Milan, Italy. It is known for research contribution in the topics: Population & Medicine. The organization has 58413 authors who have published 139784 publications receiving 4636354 citations. The organization is also known as: Università degli Studi di Milano & Statale.
Topics: Population, Medicine, Cancer, Blood pressure, Transplantation
Papers published on a yearly basis
Papers
More filters
••
1,113 citations
••
TL;DR: Empirical support is presented for the notion that changes in specific neural networks that hold an updated map of body shape and posture are compatible with the inclusion of tools in the "Body Schema", as if the hand were elongated to the tip of the tool.
1,110 citations
••
TL;DR: The availability of effective therapy for this often lethal disease emphasizes the importance of early and accurate diagnosis, and there is frequently a delay in the diagnosis of LQTS, and patients with syncope are often misdiagnosed.
Abstract: T he idiopathic long QT syndrome (LQTS) is a congenital disease with frequent familial transmission, characterized primarily by prolongation of the QT interval and by the occurrence of life-threatening tachyarrhythmias, particularly in association with emotional or physical stress.1-5 Among untreated symptomatic patients, lethality is high, with 20% mortality in the first year after the initial syncope and approximately 50% within 10 years3; however, the risk of death varies among different families. This poor prognosis has been significantly improved by the use of pharmacological or surgical antiadrenergic therapy or both, which has reduced long-term mortality to <5%.3,4,6 The availability of effective therapy for this often lethal disease emphasizes the importance of early and accurate diagnosis. Unfortunately, there is frequently a delay in the diagnosis of LQTS, and patients with syncope are often misdiagnosed, most commonly as affected by a seizure disorder. In its most characteristic presentation, with obvious QT prolongation and stress-induced syncope, the diagnosis of LQTS is quite straightforward for physicians aware of the disease. In cases of borderline QT prolongation and/or absence of symptoms, however, a correct diagnosis may be more difficult. It was for this reason that a first set of diagnostic criteria (Table 1) was proposed in 1985.3 The major merit of that proposal was that it provided a logical and quantitative approach to the clinical diagnosis of LQTS by giving a different weight to major and minor criteria. Its major limitation was that it used the traditional, but untested for diagnostic purposes, cutoff value of QT, >440 msec '2. This also resulted in a rather black-and-white situation in which patients were judged to have an entirely normal or abnormal duration of ventricular repolarization on the basis of a difference of a few milliseconds in a measurement fraught with difficulties, such as interobserver variability.7
1,106 citations
••
French Institute of Health and Medical Research1, University of Florence2, RWTH Aachen University3, University of Florida4, Duke University5, Brigham and Women's Hospital6, University of Milan7, University of Strasbourg8, University of Tennessee Health Science Center9, Technische Universität München10, Scripps Health11, MedStar Washington Hospital Center12
TL;DR: A consensus opinion is provided on the definition of high on-treatment platelet reactivity to ADP based on various methods reported in the literature and how this measurement may be used in the future care of patients.
1,105 citations
••
University of North Carolina at Chapel Hill1, University of Texas Health Science Center at Houston2, University of Pavia3, University of Cambridge4, University of Milan5, Stanford University6, Kaiser Permanente7, National Institutes of Health8, University of Washington9, Wake Forest University10, Cedars-Sinai Medical Center11, Group Health Cooperative12, Lund University13, University of Michigan14, University of Helsinki15, National Institute for Health and Welfare16, Boston University17, University of Chicago18, International Agency for Research on Cancer19, Charles University in Prague20, French Institute of Health and Medical Research21, Institut Gustave Roussy22, University of Padua23, University of Glasgow24, Palacký University, Olomouc25, Trinity College, Dublin26, National and Kapodistrian University of Athens27, Newcastle University28, University of Aberdeen29, University of Turin30, Nofer Institute of Occupational Medicine31, Russian Academy32, University of Exeter33, Harvard University34, Massachusetts Institute of Technology35, Broad Institute36, VU University Amsterdam37, Erasmus University Rotterdam38, University of Virginia39, Virginia Commonwealth University40, University of Pennsylvania41, Duke University42, Tufts University43, University of Ioannina44
TL;DR: A meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium found the strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3, and three loci associated with number of cigarettes smoked per day were identified.
Abstract: Consistent but indirect evidence has implicated genetic factors in smoking behavior1,2. We report meta-analyses of several smoking phenotypes within cohorts of the Tobacco and Genetics Consortium (n = 74,053). We also partnered with the European Network of Genetic and Genomic Epidemiology (ENGAGE) and Oxford-GlaxoSmithKline (Ox-GSK) consortia to follow up the 15 most significant regions (n > 140,000). We identified three loci associated with number of cigarettes smoked per day. The strongest association was a synonymous 15q25 SNP in the nicotinic receptor gene CHRNA3 (rs1051730[A], b = 1.03, standard error (s.e.) = 0.053, beta = 2.8 x 10(-73)). Two 10q25 SNPs (rs1329650[G], b = 0.367, s. e. = 0.059, beta = 5.7 x 10(-10); and rs1028936[A], b = 0.446, s. e. = 0.074, beta = 1.3 x 10(-9)) and one 9q13 SNP in EGLN2 (rs3733829[G], b = 0.333, s. e. = 0.058, P = 1.0 x 10(-8)) also exceeded genome-wide significance for cigarettes per day. For smoking initiation, eight SNPs exceeded genome-wide significance, with the strongest association at a nonsynonymous SNP in BDNF on chromosome 11 (rs6265[C], odds ratio (OR) = 1.06, 95% confidence interval (Cl) 1.04-1.08, P = 1.8 x 10(-8)). One SNP located near DBH on chromosome 9 (rs3025343[G], OR = 1.12, 95% Cl 1.08-1.18, P = 3.6 x 10(-8)) was significantly associated with smoking cessation.
1,104 citations
Authors
Showing all 58902 results
Name | H-index | Papers | Citations |
---|---|---|---|
Yi Cui | 220 | 1015 | 199725 |
Peter J. Barnes | 194 | 1530 | 166618 |
Thomas C. Südhof | 191 | 653 | 118007 |
Charles A. Dinarello | 190 | 1058 | 139668 |
Alberto Mantovani | 183 | 1397 | 163826 |
John J.V. McMurray | 178 | 1389 | 184502 |
Giuseppe Remuzzi | 172 | 1226 | 160440 |
Russel J. Reiter | 169 | 1646 | 121010 |
Jean Louis Vincent | 161 | 1667 | 163721 |
Tobin J. Marks | 159 | 1621 | 111604 |
Tomas Hökfelt | 158 | 1033 | 95979 |
José Baselga | 156 | 707 | 122498 |
Naveed Sattar | 155 | 1326 | 116368 |
Silvia Franceschi | 155 | 1340 | 112504 |
Frederik Barkhof | 154 | 1449 | 104982 |